Skip to content

The Clinical Trials for Effectiveness and Safety of the New Developed, Low powered Light Irradiation Equipment (Bye-Vi) for Patients with Common Cold

The Clinical Trials for Effectiveness and Safety of the New Developed, Low powered Light Irradiation Equipment (Bye-Vi) for Patients with Common Cold, Single Center, Randomized Controlled, Parallel Design, Double Blinding, Superiority, Prospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007255
Enrollment
20
Registered
2022-05-06
Start date
2022-03-30
Completion date
Unknown
Last updated
2023-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : - Control group : Using green light sham-device which has same design and shape with real device, 2~3 times one day, 3~4 days, total 9 times at house. - Experimental group : Using rea

Sponsors

Nanobioimaging
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adult men and women aged 19 to 65 2) Patients with cold symptoms 48 hours prior to participation in the test 3) Those who have at least 1 point each of the 4 symptoms of sore throat, cough, sneeze, and runny nose, which are common local symptoms among the 8* cold symptoms 4) Agreed not to take any cold-related medication while participating in clinical trials 5) A person who fully understands the purpose and procedures of the study and wishes to participate in the clinical study with voluntary consent

Exclusion criteria

Exclusion criteria: 1) A person who has known light sensitivity or photoallergy 2) A person whose body temperature is 37.5 degrees Celsius or higher 3) Currently, people with allergic rhinitis, chronic obstructive pulmonary disease (COPD), and severe nasal syndrome 4) A person with symptoms that may cause nasal congestion due to nasal polyps, past nasal/narcotic surgery, and score 5) People with a history of alcoholism, drug abuse or prescription/nonconforming drug use (e.g. contraceptives, systemic steroids, nasal dosing, antibiotics, etc.) 6) A person who has symptoms of infection other than respiratory tract

Design outcomes

Primary

MeasureTime frame
Comparative evaluation before and after treatment using Jackson Symptom Score

Secondary

MeasureTime frame
Body weight check, Body temperature, blood pressure, complete blood cell count with difference count, C-reactive protein (CRP), virus polymerase chain reaction (vPCR)

Countries

Korea, Republic of

Contacts

Public ContactYong Tae Hong

Jeonbuk National University

centennialman@hanmail.net+82-63-259-3471

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026